Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2045-2322
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
Cisplatin shows greater efficacy than gemcitabine when combined with nab-paclitaxel in metastatic triple-negative breast cancer ; volume:9 ; number:1 ; day:5 ; month:3 ; year:2019 ; pages:1-8 ; date:12.2019
Scientific reports ; 9, Heft 1 (5.3.2019), 1-8, 12.2019

Classification
Naturwissenschaften

Creator
Li, Yi
Zhao, Yannan
Gong, Chengcheng
Xie, Yizhao
Hu, Xichun
Zhang, Jian
Wang, Leiping
Zhang, Sheng
Cao, Jun
Tao, Zhonghua
Wang, Biyun
Contributor
SpringerLink (Online service)

DOI
10.1038/s41598-019-39314-y
URN
urn:nbn:de:101:1-2019032418384379938102
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
14.08.2025, 10:48 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Li, Yi
  • Zhao, Yannan
  • Gong, Chengcheng
  • Xie, Yizhao
  • Hu, Xichun
  • Zhang, Jian
  • Wang, Leiping
  • Zhang, Sheng
  • Cao, Jun
  • Tao, Zhonghua
  • Wang, Biyun
  • SpringerLink (Online service)

Other Objects (12)

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

The China-United States BIT negotiations: A Chinese perspective

Bericht

The China-United States BIT negotiations: A Chinese perspective

Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study

Nab-paclitaxel and gemcitabine plus camrelizumab and radiotherapy versus nab-paclitaxel and gemcitabine alone for locally advanced pancreatic adenocarcinoma: a prospective cohort study

Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases

Phase II trial of nab-paclitaxel in metastatic breast cancer patients with visceral metastases

Pankreaskarzinom nab-Paclitaxel

Pankreaskarzinom nab-Paclitaxel

Towards a sub-percent precision measurement of sin2 θ 13 with reactor antineutrinos

Towards a sub-percent precision measurement of sin2 θ 13 with reactor antineutrinos

Ventral striatal dysfunction in cocaine dependence – difference mapping for subregional resting state functional connectivity

Ventral striatal dysfunction in cocaine dependence – difference mapping for subregional resting state functional connectivity

Breast cancer nab-Paclitaxel

Breast cancer nab-Paclitaxel

Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer

Sulindac (K-80003) with nab-paclitaxel and gemcitabine overcomes drug-resistant pancreatic cancer

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer

Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine

Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer Responding to Nab-Paclitaxel plus Gemcitabine

Unlocking high-performance HCl adsorption at elevated temperatures: the synthesis and characterization of robust Ca–Mg–Al mixed oxides

Unlocking high-performance HCl adsorption at elevated temperatures: the synthesis and characterization of robust Ca–Mg–Al mixed oxides

Related objects